Secondary malignant neoplasm of lymph node
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
In addition, esophageal cancer patients with Ⅲ-Ⅳ, T3-T4 or positive lymph node metastasis had lower RPL34-AS1expression levels than esophageal cancer patients with Ⅰ-Ⅱ, T1-T2 or negative lymph node metastasis, respectively.
|
31574377 |
2019 |
Secondary malignant neoplasm of lymph node
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The RPL34 expression was significantly correlated with differentiation degree, TNM stage and lymph node metastasis.
|
28697409 |
2017 |
Non-Small Cell Lung Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These data indicate that over-expressed RPL34 may promote malignant proliferation of NSCLC cells, thus playing an important role in development and progress of NSCLC.
|
26526135 |
2016 |
Mental Depression
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results suggest that ribosomal genes, particularly RPL17 and RPL34, can play integral roles in stress vulnerability and depression across nonclinical and clinical conditions.
|
30103068 |
2018 |
Depressive disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results suggest that ribosomal genes, particularly RPL17 and RPL34, can play integral roles in stress vulnerability and depression across nonclinical and clinical conditions.
|
30103068 |
2018 |
Glioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, RPL34 may serve as a potential therapeutic target for the treatment of glioma.
|
30216512 |
2019 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We further used lentivirus-mediated small interfering RNAs (siRNAs) to knockdown RPL34 expression in the human gastric cancer cell line SGC-7901.
|
26323242 |
2015 |
Osteosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our findings suggest that RPL34 plays an important role in the proliferation of osteosarcoma cells.
|
27883047 |
2016 |
Retinoblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A computerized sequence analysis revealed highly conserved motifs with possible functional meaning: two domains that, in the RBP2 homolog, mediate the binding and interaction with the proteins encoded by the retinoblastoma susceptibility gene, the TATA-binding protein, and the oncoprotein rhombotin 2; in addition, two DNA-binding zinc finger/leukemia-associated protein motifs were detected.
|
10616211 |
1999 |
synovial sarcoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10.
|
11423977 |
2001 |
Unipolar Depression
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, the upregulation of RPL17 and RPL34 was most marked in DSM-IV major depressive disorder, followed by in bipolar disorder, and then in schizophrenia, suggesting some diagnostic specificity of these markers as well as their general roles in stress vulnerability.
|
30103068 |
2018 |
Esophageal carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of RPL34 efficiently inhibited esophageal cancer cell proliferation, migration, and invasion in vitro.
|
28109079 |
2017 |
Pancreatic carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We revealed that RPL34 acts as a potential onco-protein in PC, and RPL34 may be a promising biomarker for prognosis prediction and a potential target for the treatment of PC.
|
27845896 |
2016 |
Adult Synovial Sarcoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10.
|
11423977 |
2001 |
Childhood Synovial Sarcoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10.
|
11423977 |
2001 |
Malignant neoplasm of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
We revealed that RPL34 acts as a potential onco-protein in PC, and RPL34 may be a promising biomarker for prognosis prediction and a potential target for the treatment of PC.
|
27845896 |
2016 |
Malignant neoplasm of esophagus
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of RPL34 efficiently inhibited esophageal cancer cell proliferation, migration, and invasion in vitro.
|
28109079 |
2017 |
Osteosarcoma of bone
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our findings suggest that RPL34 plays an important role in the proliferation of osteosarcoma cells.
|
27883047 |
2016 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We further used lentivirus-mediated small interfering RNAs (siRNAs) to knockdown RPL34 expression in the human gastric cancer cell line SGC-7901.
|
26323242 |
2015 |
Major Depressive Disorder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, the upregulation of RPL17 and RPL34 was most marked in DSM-IV major depressive disorder, followed by in bipolar disorder, and then in schizophrenia, suggesting some diagnostic specificity of these markers as well as their general roles in stress vulnerability.
|
30103068 |
2018 |
Childhood Osteosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our findings suggest that RPL34 plays an important role in the proliferation of osteosarcoma cells.
|
27883047 |
2016 |
Tumor Cell Invasion
|
0.040 |
AlteredExpression
|
phenotype |
BEFREE |
The qRT-PCR and western blot were performed to measure RPL34 expression, CCK-8 and flow cytometry to observe cell growth and apoptosis, and wound healing and transwell to detect cell migration and invasion.
|
28697409 |
2017 |
Tumor Cell Invasion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Knockdown of RPL34 efficiently inhibited esophageal cancer cell proliferation, migration, and invasion in vitro.
|
28109079 |
2017 |
Tumor Cell Invasion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Knockdown of RPL34 markedly inhibited the proliferation, migration, and invasion, as well as prevented the epithelial-mesenchymal transition phenotype in glioma cells.
|
30216512 |
2019 |
Tumor Cell Invasion
|
0.040 |
AlteredExpression
|
phenotype |
BEFREE |
Our in vitro experiments suggested RPL34-AS1 inhibits esophageal cancer cell proliferation, migration and invasion through down-regulating RPL34 expression.
|
31574377 |
2019 |